版本:
中国

BRIEF-AbbVie and Principia to collaborate on oral immunoproteasome inhibitors

June 13 AbbVie Inc-

* AbbVie and Principia announce collaboration on oral immunoproteasome inhibitors

* Financial terms were not disclosed

* AbbVie - upon successful completion, co will be responsible for ongoing clinical development and commercialization of viable compounds resulting from partnership

* AbbVie and Principia will collaborate on research and pre-clinical studies Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐